Company profile
CorrGene company profile
CorrGene is an innovative company focusing on the research and development and production of new anti-cancer drugs and rare diseases with gene editing technology and cell therapy. The company was established by a group of cell and gene therapy experts, virologists, oncologists, hematologists and biopharmaceutical industry veterans. CorrGene was established in January, 2022 in Jiangsu, China.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2022-01-01
Headquarters
- Headquarters
- Ning’er, Yunnan, China
- Country code
- CN
- Continent
- Asia